Skip to main content

Limb-Girdle Muscular Dystrophy Type 2D

  • Chapter
  • First Online:
Genetic Neuromuscular Disorders
  • 156 Accesses

Abstract

The LGMD due to mutations which affect members of the sarcoglycan complex can be due to poor assembly of the complex and loss of alpha-sarcoglycan ecto-ATPase function. Indeed, the first member of the complex was identified in 1993 in cases where alpha-sarcoglycan protein was absent due to mutations in the SGCA gene. The protein was originally named “adhalin” by Fardeau, because of the Arabic name of muscle which is “adhal.” Its protein defect was recognized to cause the original patients with Duchenne-like females or males and later also a variety of phenotypes in adult cases. Some of them have been treated also with steroids for their similarities to Duchenne dystrophy pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Duggan DJ, Fanin M, Pegoraro E, Angelini C, Hoffman EP. Alpha-sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations. J Neurol Sci. 1996;140:30–9.

    Article  CAS  PubMed  Google Scholar 

  2. Duggan DJ, Gorospe JRM, Fanin M, Hoffman EP, Angelini C. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med. 1997;336:618–24.

    Article  CAS  PubMed  Google Scholar 

  3. Angelini C, Fanin M, Menegazzo E, et al. Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid responsive mild LGMD patient. Muscle Nerve. 1998;21:769–75.

    Article  CAS  PubMed  Google Scholar 

  4. Fanin M, Duggan DJ, Mostacciuolo ML, et al. Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J Med Genet. 1997;34:973–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Angelini C, Fanin M, Freda MP, Duggan DJ, Siciliano G, Hoffman EP. The clinical spectrum of sarcoglycanopathies. Neurology. 1999;52:176–9.

    Article  CAS  PubMed  Google Scholar 

  6. Boito C, Fanin M, Siciliano G, Angelini C, Pegoraro E. Novel sarcoglycan gene mutations in a large cohort of Italian patients. J Med Genet. 2003;40:67–73.

    Article  Google Scholar 

  7. Melacini P, Fanin M, Duggan DJ, et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve. 1999;22:473–9.

    Article  CAS  PubMed  Google Scholar 

  8. Meznaric-Petrusa M, Kralj E, Angelini C, Fanin M, Trinkaus D. Cardiomyopathy in a patient with limb-girdle muscular dystrophy type 2D: pathomorphological aspects. Forensic Sci Int. 2009;1:58–62.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Angelini, C. (2018). Limb-Girdle Muscular Dystrophy Type 2D. In: Genetic Neuromuscular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-56454-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56454-8_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56453-1

  • Online ISBN: 978-3-319-56454-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics